Epigral Limited, a leading integrated manufacturer of chemicals in India, at it’s Fund Raising Comittee meeting approved the issue and allotment of 15.91 lakh shares.
Epigrel Limited in the allotment sells 15.91 lakh shares at the price of Rs. 2093.12 per share including a premium of Rs. 2083.13 per equity shares aggregating to Rs. 333.05 crores.
The Company informs the exchange on October 24.
Also Read Le Travenues Technology acquires 51% stake of ‘Zoop’
One thought on “Epigral Limited raises funding of Rs. 333 crores”